Literature DB >> 20436547

Biomechanical considerations: evaluating scleral reinforcement materials for pathological myopia.

Zhipeng Yan1, Chaoying Wang, Weiyi Chen, Xiujun Song.   

Abstract

OBJECTIVE: Scleral biomechanical weakness and thinness are known to be one of the main factors in the pathogenesis of progressive myopia. Posterior scleral reinforcement surgery remains the rational treatment for pathological myopia. We tested the biomechanical properties of 3 types of scleral reinforcement materials (artificial pericardium, human sclera, and all-dermal matrix) in an attempt to select the ideal material for the reinforcement of pathologic sclera.
DESIGN: Experimental study. PARTICIPANTS: Forty-five adult Japanese white rabbits.
METHODS: Animals were equally divided into 3 groups. For each group, 1 type of material was surgically implanted at the back of the globe. We harvested samples after 10 months of implantation, tested the elasticity modulus for both reinforced sclera and unreinforced control sclera, and assessed data by t test methods. Statistically significant differences were considered when p < 0.05.
RESULTS: Rabbit sclera reinforced by artificial pericardium or human sclera showed significant increases in the elasticity modulus compared with control eyes. However, the rabbit sclera reinforced by all-dermal matrix showed no significant difference in the elasticity modulus compared with normal controls.
CONCLUSIONS: The analysis of biomechanical considerations in scleral reinforcement materials presented here is a very helpful method to choose the best materials for treatment of myopia. Of all materials tested, the artificial pericardium and human foreign-body sclera provided the best biomechanical characteristics.

Entities:  

Mesh:

Year:  2010        PMID: 20436547     DOI: 10.3129/i09-279

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  Posterior scleral reinforcement combined with patching therapy for pre-school children with unilateral high myopia.

Authors:  Zhao-Meng Shen; Zhen-Yong Zhang; Lin-Yi Zhang; Zhi-Guo Li; Ren-Yuan Chu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-19       Impact factor: 3.117

2.  Clinical observation of posterior scleral reinforcement in the treatment of progressive high myopia in Chinese children: a retrospective study.

Authors:  Shouming Gao; Yuanlong Liu; Shuting Ma; Lixia Li; Yanyan Mao
Journal:  BMC Ophthalmol       Date:  2022-04-01       Impact factor: 2.209

3.  Modified Posterior Scleral Reinforcement as a Treatment for High Myopia in Children and Its Therapeutic Effect.

Authors:  Zequn Miao; Luojia Li; Xiaoli Meng; Lili Guo; Di Cao; Yanlei Jia; Dongmei He; Lvzhen Huang; Lejin Wang
Journal:  Biomed Res Int       Date:  2019-01-22       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.